Absci Corp (ABSI) Stock Price, Quote & News

Company Profile

Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration...

Industry: Biotechnology

Sector: Healthcare

Phone: 360 949 1041

Website: www.absci.com

Address:

18105 SE Mill Plain Boulevard, Vancouver, United States

septrading Sep. 23 at 1:07 AM

$ABSI a good short ride, but I'm cashing out.

0 · Reply

MAs_Crxss Sep. 22 at 10:09 PM

$OPEN where are those people that blocked me for my $AMD position? How bout the ones that talked shit for my quantum positions (oh they make no money) How about $GME ? Media wants to hype up INTC (owned at 20.00) CEOs purchase of 10M+ a couple weeks ago, but no one bats an eye at Ryan buying over 68M$ worth of stock this year alone?? How about how $OPEN is going to be the reason the next housing cycle exists? How about $ABSI ? look up the ceos Ted talk. Bears are outta their marbles. Including burry.

1 · Reply

woodhous Sep. 22 at 6:54 PM

$ABSI

2 · Reply

Doozio Sep. 22 at 6:38 PM

$ABSI ONTA the DLO!!!!!

0 · Reply

JFDI Sep. 22 at 3:51 PM

$ABSI stage 2 continuation thru 12.12

0 · Reply

Negavulin Sep. 22 at 3:31 PM

$ABSI always mark my words

0 · Reply

SherryDubya Sep. 22 at 3:21 PM

$ABSI https://www.fiercebiotech.com/biotech/his-parents-basement-your-medicine-cabinet-absci-ceo-endeavors-create-biotechs-apple

0 · Reply

AnomalyDetective Sep. 22 at 1:55 PM

💥 $ABSI the 2nd pick of the week to break 10% through Tuesday for members with a strong history of large MDA breakout moves. Simulated portfolio is up 171.55% YTD average cumulative returns through 38 weeks. ✅ Extending the count to 381 weeks with at least one weekly breakout selection gaining over 10% in less than a week. Credit: http://vmbreakouts.com @vmbreakouts 🏆 Many more free prior selections at http://top.vmbreakouts.com

0 · Reply

Negavulin Sep. 22 at 1:46 PM

$ABSI $11 coming

1 · Reply

7m3835d3 Sep. 22 at 1:43 PM

$ABSI love this price action. Particularly, this is really great to see for anyone who got in early and held through volatility for years. December is right around the corner! 2027 is packed with milestones as well!

1 · Reply

Absci Transcript: Morgan Stanley 24th Annual Global Healthcare Conference

Sep 15, 2026, 3:30 PM EDT - 7 days ago

Absci Transcript: H.C. Wainwright 28th Annual Global Investment Conference

2026-09-09T10:25:13.000Z - 13 days ago

Absci initiated with an Outperform at LifeSci Capital

2026-09-08T11:11:08.000Z - 14 days ago

Absci price target raised to $15 from $13 at BTIG

Sep 1, 2026, 8:00 AM EDT - 21 days ago

Absci to Participate in Upcoming Investor Conferences

2026-08-17T11:12:03.000Z - 5 weeks ago

Absci reports Q2 EPS (21c), consensus (20c)

Aug 11, 2026, 4:30 PM EDT - 6 weeks ago

Absci Earnings Call Transcript: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 6 weeks ago

Absci Earnings release: Q2 2026

Aug 11, 2026, 4:30 PM EDT - 6 weeks ago

Absci Quarterly report: Q2 2026

Aug 11, 2026, 4:05 PM EDT - 6 weeks ago

Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results

Aug 11, 2026, 7:00 AM EDT - 6 weeks ago

Absci Slides: Corporate presentation

2026-07-21T19:20:11.000Z - 2 months ago

Absci management to meet virtually with KeyBanc

Jul 14, 2026, 4:05 PM EDT - 2 months ago

Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026

2026-07-07T00:00:10.000Z - 2 months ago

Absci director buys $149K in common stock

Jun 26, 2026, 2:39 PM EDT - 2 months ago

Healthcare stocks have become a haven for investors ditching tech

ABBV APGE JNJ LLY MRNA SNY XBI

2026-06-25T10:50:47.000Z - 2 months ago

Absci price target raised to $10 from $4.10 at Morgan Stanley

2026-06-25T10:06:19.000Z - 2 months ago

Absci price target raised to $16 from $8 at H.C. Wainwright

2026-06-24T10:40:14.000Z - 3 months ago

Absci prices 13.5M shares at $7.41 in public offering

2026-06-24T10:35:24.000Z - 3 months ago

Absci reports Phase 1 data from human trial of ABS-201

Jun 24, 2026, 6:35 AM EDT - 3 months ago

Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors

Jun 24, 2026, 6:30 AM EDT - 3 months ago

Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)

2026-06-15T10:40:07.000Z - 3 months ago

Absci price target raised to $15 from $10 at Guggenheim

Jun 12, 2026, 9:00 AM EDT - 3 months ago

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery

HYFT

Jun 9, 2026, 3:20 PM EDT - 3 months ago

Absci Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 9, 2026, 3:20 PM EDT - 3 months ago

Absci Slides: FY 2026

Jun 4, 2026, 9:00 AM EDT - 3 months ago

Absci Transcript: AGM 2026

2026-06-04T10:38:54.000Z - 3 months ago

Absci initiated with an Outperform at Leerink

Jun 3, 2026, 7:35 AM EDT - 3 months ago

Absci Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 7:35 AM EDT - 3 months ago

Absci Slides: FY 2026

2026-05-28T11:20:41.000Z - 3 months ago

Absci initiated with a Buy at BTIG

2026-05-14T17:07:20.000Z - 4 months ago

Absci price target lowered to $4.10 from $4.20 at Morgan Stanley

2026-05-13T08:40:11.000Z - 4 months ago

Absci price target raised to $11 from $9 at JonesResearch

2026-05-07T22:23:30.000Z - 4 months ago

Absci reports Q1 EPS (19c), consensus (20c)

May 7, 2026, 4:30 PM EDT - 4 months ago

Absci Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Absci Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 4 months ago

Absci Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 4 months ago

Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results

May 7, 2026, 4:00 PM EDT - 4 months ago

Absci Slides: Corporate presentation

May 4, 2026, 8:11 PM EDT - 4 months ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 23, 2026, 4:05 PM EDT - 5 months ago

Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026

Apr 22, 2026, 8:00 AM EDT - 5 months ago

Absci Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 5 months ago

Absci Proxy statement: Proxy filing

Apr 16, 2026, 1:30 PM EDT - 5 months ago

Absci Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 8:00 AM EDT - 5 months ago

Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

2026-03-25T11:35:46.000Z - 6 months ago

Absci price target lowered to $4.20 from $4.32 at Morgan Stanley

Mar 24, 2026, 4:30 PM EDT - 6 months ago

Absci Earnings Call Transcript: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 6 months ago

Absci Annual report: Q4 2025

Mar 24, 2026, 4:30 PM EDT - 6 months ago

Absci Earnings release: Q4 2025

Mar 24, 2026, 4:05 PM EDT - 6 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 9, 2026, 10:00 AM EDT - 6 months ago

Absci Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 8:00 AM EST - 6 months ago

Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer

Mar 2, 2026, 9:10 AM EST - 6 months ago

Absci Transcript: TD Cowen 46th Annual Health Care Conference

Feb 24, 2026, 8:00 AM EST - 7 months ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026

Jan 14, 2026, 6:45 PM EST - 8 months ago

Absci Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:45 PM EST - 8 months ago

Absci Slides: 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:00 AM EST - 9 months ago

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 11, 2025, 10:00 AM EST - 9 months ago

Absci Transcript: Status Update

Dec 11, 2025, 10:00 AM EST - 9 months ago

Absci Press release: Status Update

Dec 11, 2025, 10:00 AM EST - 9 months ago

Absci Slides: Status Update

Dec 11, 2025, 8:00 AM EST - 9 months ago

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Dec 10, 2025, 8:00 AM EST - 9 months ago

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Dec 4, 2025, 8:00 AM EST - 9 months ago

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Nov 18, 2025, 4:30 AM EST - 10 months ago

Absci Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 4:30 AM EST - 10 months ago

Absci Slides: FY 2025

Nov 12, 2025, 4:30 PM EST - 10 months ago

Absci Earnings Call Transcript: Q3 2025

Nov 12, 2025, 4:30 PM EST - 10 months ago

Absci Quarterly report: Q3 2025

Nov 12, 2025, 4:30 PM EST - 10 months ago

Absci Earnings release: Q3 2025

Nov 12, 2025, 4:05 PM EST - 10 months ago

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Nov 10, 2025, 10:00 AM EST - 10 months ago

Absci Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference

Oct 29, 2025, 4:05 PM EDT - 10 months ago

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Oct 15, 2025, 8:00 AM EDT - 11 months ago

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Sep 11, 2025, 8:00 AM EDT - 1 year ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 9, 2025, 9:30 AM EDT - 1 year ago

Absci Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 3:20 PM EDT - 1 year ago

Absci Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 25, 2025, 4:05 PM EDT - 1 year ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Absci Quarterly report: Q2 2025

Aug 12, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings release: Q2 2025

Aug 12, 2025, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 12, 2025, 8:00 AM EDT - 1 year ago

Absci Registration statement: Registration Filing

Aug 7, 2025, 2:00 AM EDT - 1 year ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Jul 30, 2025, 4:05 PM EDT - 1 year ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 24, 2025, 8:45 PM EDT - 1 year ago

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 1 year ago

Absci Announces Proposed Public Offering of Common Stock

Jul 7, 2025, 8:00 AM EDT - 1 year ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Jun 9, 2025, 8:40 AM EDT - 1 year ago

Absci Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 5, 2025, 2:00 PM EDT - 1 year ago

Absci Transcript: Jefferies Global Healthcare Conference 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Absci Quarterly report: Q1 2025

May 13, 2025, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:01 PM EDT - 1 year ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Absci Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Absci Proxy statement: Proxy Filing

Apr 14, 2025, 4:05 PM EDT - 1 year ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 8, 2025, 11:45 AM EDT - 1 year ago

Absci Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025, 10:30 AM EDT - 1 year ago

Absci Transcript: H.C. Wainwright 2nd Annual Artificial Intelligence Based Drug Discovery & Development Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Absci Registration statement: Registration Filing

Mar 19, 2025, 9:00 AM EDT - 1 year ago

Absci Transcript: KeyBanc Annual Health Care Forum 2025

Mar 19, 2025, 9:00 AM EDT - 1 year ago

Absci Slides: FY 2025

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings Call Transcript: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Annual report: Q4 2024

Mar 18, 2025, 4:30 PM EDT - 1 year ago

Absci Earnings release: Q4 2024

Mar 18, 2025, 4:05 PM EDT - 1 year ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 4, 2025, 4:05 PM EST - 1 year ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 3, 2025, 3:10 PM EST - 1 year ago

Absci Transcript: TD Cowen 45th Annual Healthcare Conference

Feb 18, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 5, 2025, 3:00 PM EST - 1 year ago

Absci Transcript: Guggenheim SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 15, 2025, 7:30 PM EST - 1 year ago

Absci Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

Absci Slides: FY 2025

Jan 10, 2025, 7:30 AM EST - 1 year ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 1 year ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 6, 2025, 8:00 AM EST - 1 year ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Transcript: R&D Day 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Press release: FY 2024

Dec 12, 2024, 9:00 AM EST - 1 year ago

Absci Slides: FY 2024

Nov 18, 2024, 1:50 PM EST - 1 year ago

Absci Transcript: Stifel 2024 Healthcare Conference

Nov 13, 2024, 10:15 AM EST - 1 year ago

Absci Transcript: UBS Global Healthcare Conference

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Quarterly report: Q3 2024

Nov 12, 2024, 8:00 AM EST - 1 year ago

Absci Earnings release: Q3 2024

Nov 12, 2024, 7:30 AM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 11, 2024, 10:00 AM EST - 1 year ago

Absci Transcript: Guggenheim Inaugural Global Healthcare Conference

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Sep 10, 2024, 11:00 AM EDT - 2 years ago

Absci Transcript: H.C. Wainwright 26th Annual Global Investment Conference

Sep 5, 2024, 5:35 PM EDT - 2 years ago

Absci Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Earnings Call Transcript: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Quarterly report: Q2 2024

Aug 14, 2024, 4:30 PM EDT - 2 years ago

Absci Earnings release: Q2 2024

Aug 14, 2024, 4:01 PM EDT - 2 years ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Jul 10, 2024, 8:00 AM EDT - 2 years ago

Absci to Report Business Updates and Second Quarter 2024 Financial and Operating Results on August 14, 2024

Jun 10, 2024, 2:00 PM EDT - 2 years ago

Absci Transcript: Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 8:00 AM EDT - 2 years ago

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Earnings Call Transcript: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Quarterly report: Q1 2024

May 14, 2024, 8:00 AM EDT - 2 years ago

Absci Earnings release: Q1 2024

May 14, 2024, 7:30 AM EDT - 2 years ago

Absci Reports Business Updates and First Quarter 2024 Financial and Operating Results

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Absci Proxy statement: Proxy Filing

Apr 23, 2024, 8:00 AM EDT - 2 years ago

Absci Proxy statement: Proxy Filing

Apr 8, 2024, 3:00 PM EDT - 2 years ago

Absci Transcript: 23rd Annual Needham Virtual Healthcare Conference

Mar 21, 2024, 7:30 AM EDT - 2 years ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Absci Annual report: Q4 2023

Mar 21, 2024, 7:00 AM EDT - 2 years ago

Absci Earnings release: Q4 2023

Mar 19, 2024, 10:30 AM EDT - 2 years ago

Absci Transcript: KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Mar 7, 2024, 10:30 AM EST - 2 years ago

Absci Transcript: H.C. Wainwright 1st Annual AI Based Drug Discovery & Development Conference (Virtual)

Mar 6, 2024, 12:00 PM EST - 2 years ago

Absci Transcript: KeyBanc’s Emerging Technology Summit

Mar 4, 2024, 2:10 PM EST - 2 years ago

Absci Transcript: TD Cowen 44th Annual Health Care Conference

Mar 1, 2024, 4:01 PM EST - 2 years ago

Absci Announces Closing of Public Offering of Common Stock Including Full Exercise of the Underwriters' Option to Purchase Additional Shares

septrading Sep. 23 at 1:07 AM

$ABSI a good short ride, but I'm cashing out.

0 · Reply

MAs_Crxss Sep. 22 at 10:09 PM

1 · Reply

woodhous Sep. 22 at 6:54 PM

$ABSI

2 · Reply

Doozio Sep. 22 at 6:38 PM

$ABSI ONTA the DLO!!!!!

0 · Reply

JFDI Sep. 22 at 3:51 PM

$ABSI stage 2 continuation thru 12.12

0 · Reply

Negavulin Sep. 22 at 3:31 PM

$ABSI always mark my words

0 · Reply

SherryDubya Sep. 22 at 3:21 PM

$ABSI https://www.fiercebiotech.com/biotech/his-parents-basement-your-medicine-cabinet-absci-ceo-endeavors-create-biotechs-apple

0 · Reply

AnomalyDetective Sep. 22 at 1:55 PM

0 · Reply

Negavulin Sep. 22 at 1:46 PM

$ABSI $11 coming

1 · Reply

7m3835d3 Sep. 22 at 1:43 PM

1 · Reply

Negavulin Sep. 22 at 9:49 AM

$ABSI breaks $11 eow

0 · Reply

CydoniaAnhedonia Sep. 21 at 8:05 PM

$ABSI Excellent

0 · Reply

Negavulin Sep. 21 at 1:05 PM

$ABSI breaks $10 today

1 · Reply

TA_Kongen Sep. 19 at 12:10 PM

$AIFF $BFRG $LTRN $RXRX $ABSI AI drug discovery companies have potential to be one of the next hot themes. Will keep an eye on all AI Drug Discovery companies and you should too.

1 · Reply